Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.

Kambhampati S, Bauer KE, Bracci PM, Keenan BP, Behr SC, Gordan JD, Kelley RK.

Cancer. 2019 Jun 2. doi: 10.1002/cncr.32206. [Epub ahead of print]

PMID:
31154669
2.

Accurate and efficient amino acid analysis for protein quantification using hydrophilic interaction chromatography coupled tandem mass spectrometry.

Kambhampati S, Li J, Evans BS, Allen DK.

Plant Methods. 2019 May 11;15:46. doi: 10.1186/s13007-019-0430-z. eCollection 2019.

3.

Formatting References for Scientific Manuscripts.

Kambhampati SBS, Maini L.

Indian J Orthop. 2019 May-Jun;53(3):381-383. doi: 10.4103/ortho.IJOrtho_197_19. No abstract available.

4.

Higher cardiorespiratory fitness predicts long-term survival in patients with heart failure and preserved ejection fraction: the Henry Ford Exercise Testing (FIT) Project.

Orimoloye OA, Kambhampati S, Hicks AJ 3rd, Al Rifai M, Silverman MG, Whelton S, Qureshi W, Ehrman JK, Keteyian SJ, Brawner CA, Dardari Z, Al-Mallah MH, Blaha MJ.

Arch Med Sci. 2019 Mar;15(2):350-358. doi: 10.5114/aoms.2019.83290. Epub 2019 Mar 4.

5.

CT-Based 3D Printing of the Glenoid Prior to Shoulder Arthroplasty: Bony Morphology and Model Evaluation.

Wang KC, Jones A, Kambhampati S, Gilotra MN, Liacouras PC, Stuelke S, Shiu B, Leong N, Hasan SA, Siegel EL.

J Digit Imaging. 2019 Feb 28. doi: 10.1007/s10278-019-00177-4. [Epub ahead of print]

PMID:
30820811
6.

CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma.

Maity G, Ghosh A, Gupta V, Haque I, Sarkar S, Das A, Dhar K, Bhavanasi S, Gunewardena SS, Von Hoff DD, Mallik S, Kambhampati S, Banerjee SK, Banerjee S.

Mol Cancer Ther. 2019 Apr;18(4):788-800. doi: 10.1158/1535-7163.MCT-18-0899. Epub 2019 Feb 20.

PMID:
30787177
7.

Positivity Rates in Oropharyngeal and Nonoropharyngeal Head and Neck Cancer in the VA.

Park J, McPike V, Kambhampati S, Huang C, Fields-Meehan J, Verkruyse L, Allen A, Reddy E.

Fed Pract. 2018 Aug;35(Suppl 5):S44-S47.

8.

Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study.

Wang Z, Kambhampati S, Cheng Y, Ma K, Simsek C, Tieu AH, Abraham JM, Liu X, Prasath V, Duncan M, Stark A, Trick A, Tsai HL, Wang H, He Y, Khashab MA, Ngamruengphong S, Shin EJ, Wang TH, Meltzer SJ.

Clin Cancer Res. 2019 Apr 1;25(7):2127-2135. doi: 10.1158/1078-0432.CCR-18-3696. Epub 2019 Jan 22.

PMID:
30670490
9.

Comparison of Bone Marrow Biopsy Specimens Obtained Using a Motorized Device and Manual Biopsy Systems.

Glennon CA, Woodroof JM, Kambhampati S, Battershell AC, O'Connor SR, Roberts KB.

Asia Pac J Oncol Nurs. 2018 Oct-Dec;5(4):394-398. doi: 10.4103/apjon.apjon_26_18.

10.

Random Genetic Drift and Selective Pressures Shaping the Blattabacterium Genome.

Alleman A, Hertweck KL, Kambhampati S.

Sci Rep. 2018 Sep 7;8(1):13427. doi: 10.1038/s41598-018-31796-6.

11.

CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia.

Garcia-Manero G, Scott BL, Cogle CR, Boyd TE, Kambhampati S, Hetzer J, Dong Q, Kumar K, Ukrainskyj SM, Beach CL, Skikne BS.

Leuk Res. 2018 Sep;72:79-85. doi: 10.1016/j.leukres.2018.08.001. Epub 2018 Aug 3.

12.

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study.

Kim ES, Kelly K, Paz-Ares LG, Garrido P, Jalal S, Mahadevan D, Gutierrez M, Provencio M, Schaefer E, Shaheen M, Johnston EL, Turner PK, Kambhampati SRP, Beckmann R, Hossain A, John WJ, Goldman JW.

Clin Cancer Res. 2018 Nov 15;24(22):5543-5551. doi: 10.1158/1078-0432.CCR-18-0651. Epub 2018 Aug 6.

PMID:
30082474
13.

Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.

Turk BR, Nemeth CL, Marx JS, Tiffany C, Jones R, Theisen B, Kambhampati S, Ramireddy R, Singh S, Rosen M, Kaufman ML, Murray CF, Watkins PA, Kannan S, Kannan R, Fatemi A.

Ann Neurol. 2018 Sep;84(3):452-462. doi: 10.1002/ana.25303.

PMID:
30069915
14.

Scalable synthesis and validation of PAMAM dendrimer-N-acetyl cysteine conjugate for potential translation.

Sharma R, Sharma A, Kambhampati SP, Reddy RR, Zhang Z, Cleland JL, Kannan S, Kannan RM.

Bioeng Transl Med. 2018 May 25;3(2):87-101. doi: 10.1002/btm2.10094. eCollection 2018 May.

15.

Deep Learning Approach for Evaluating Knee MR Images: Achieving High Diagnostic Performance for Cartilage Lesion Detection.

Liu F, Zhou Z, Samsonov A, Blankenbaker D, Larison W, Kanarek A, Lian K, Kambhampati S, Kijowski R.

Radiology. 2018 Oct;289(1):160-169. doi: 10.1148/radiol.2018172986. Epub 2018 Jul 31.

16.

Subconjunctival dendrimer-drug therapy for the treatment of dry eye in a rabbit model of induced autoimmune dacryoadenitis.

Lin H, Liu Y, Kambhampati SP, Hsu CC, Kannan RM, Yiu SC.

Ocul Surf. 2018 Oct;16(4):415-423. doi: 10.1016/j.jtos.2018.05.004. Epub 2018 May 16.

PMID:
29777869
17.

Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock.

Hsu S, Kambhampati S, Sciortino CM, Russell SD, Schulman SP.

Am Heart J. 2018 May;199:181-191. doi: 10.1016/j.ahj.2017.11.016. Epub 2017 Dec 13.

18.

Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture.

Alnasser Y, Kambhampati SP, Nance E, Rajbhandari L, Shrestha S, Venkatesan A, Kannan RM, Kannan S.

Molecules. 2018 Apr 27;23(5). pii: E1025. doi: 10.3390/molecules23051025.

19.

Pediatric oral formulation of dendrimer-N-acetyl-l-cysteine conjugates for the treatment of neuroinflammation.

Yellepeddi VK, Mohammadpour R, Kambhampati SP, Sayre C, Mishra MK, Kannan RM, Ghandehari H.

Int J Pharm. 2018 Jul 10;545(1-2):113-116. doi: 10.1016/j.ijpharm.2018.04.040. Epub 2018 Apr 20.

PMID:
29680280
20.

The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.

Maity G, Haque I, Ghosh A, Dhar G, Gupta V, Sarkar S, Azeem I, McGregor D, Choudhary A, Campbell DR, Kambhampati S, Banerjee SK, Banerjee S.

J Biol Chem. 2018 Mar 23;293(12):4334-4349. doi: 10.1074/jbc.RA117.000333. Epub 2018 Feb 6.

21.

Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.

Haque I, Ghosh A, Acup S, Banerjee S, Dhar K, Ray A, Sarkar S, Kambhampati S, Banerjee SK.

BMC Cancer. 2018 Jan 25;18(1):99. doi: 10.1186/s12885-018-3993-6.

22.

Correction to: Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome.

Nance E, Kambhampati SP, Smith ES, Zhang Z, Zhang F, Singh S, Johnston MV, Kannan RM, Blue ME, Kannan S.

J Neuroinflammation. 2018 Jan 12;15(1):14. doi: 10.1186/s12974-018-1056-1.

23.

Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome.

Nance E, Kambhampati SP, Smith ES, Zhang Z, Zhang F, Singh S, Johnston MV, Kannan RM, Blue ME, Kannan S.

J Neuroinflammation. 2017 Dec 19;14(1):252. doi: 10.1186/s12974-017-1004-5. Erratum in: J Neuroinflammation. 2018 Jan 12;15(1):14.

24.

Correlation between markers of bone metabolism and vitamin D levels in patients with monoclonal gammopathy of undetermined significance (MGUS).

Lipe B, Kambhampati S, Veldhuizen PV, Yacoub A, Aljitawi O, Mikhael J.

Blood Cancer J. 2017 Dec 14;7(12):646. doi: 10.1038/s41408-017-0015-x. No abstract available.

25.

Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia.

Medeiros BC, McCaul K, Kambhampati S, Pollyea DA, Kumar R, Silverman LR, Kew A, Saini L, Beach CL, Vij R, Wang X, Zhong J, Gale RP.

Haematologica. 2018 Jan;103(1):101-106. doi: 10.3324/haematol.2017.172353. Epub 2017 Nov 2.

26.

Activated Microglia Targeting Dendrimer-Minocycline Conjugate as Therapeutics for Neuroinflammation.

Sharma R, Kim SY, Sharma A, Zhang Z, Kambhampati SP, Kannan S, Kannan RM.

Bioconjug Chem. 2017 Nov 15;28(11):2874-2886. doi: 10.1021/acs.bioconjchem.7b00569. Epub 2017 Oct 27.

27.

Cytosolic acetyl-CoA promotes histone acetylation predominantly at H3K27 in Arabidopsis.

Chen C, Li C, Wang Y, Renaud J, Tian G, Kambhampati S, Saatian B, Nguyen V, Hannoufa A, Marsolais F, Yuan ZC, Yu K, Austin RS, Liu J, Kohalmi SE, Wu K, Huang S, Cui Y.

Nat Plants. 2017 Oct;3(10):814-824. doi: 10.1038/s41477-017-0023-7. Epub 2017 Sep 25.

PMID:
28947800
28.

Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation.

Bhagat TD, Chen S, Bartenstein M, Barlowe AT, Von Ahrens D, Choudhary GS, Tivnan P, Amin E, Marcondes AM, Sanders MA, Hoogenboezem RM, Kambhampati S, Ramachandra N, Mantzaris I, Sukrithan V, Laurence R, Lopez R, Bhagat P, Giricz O, Sohal D, Wickrema A, Yeung C, Gritsman K, Aplan P, Hochedlinger K, Yu Y, Pradhan K, Zhang J, Greally JM, Mukherjee S, Pellagatti A, Boultwood J, Will B, Steidl U, Raaijmakers MHGP, Deeg HJ, Kharas MG, Verma A.

Cancer Res. 2017 Sep 15;77(18):4846-4857. doi: 10.1158/0008-5472.CAN-17-0282. Epub 2017 Jul 6.

29.

Effect of anesthetics on microglial activation and nanoparticle uptake: Implications for drug delivery in traumatic brain injury.

Kannan G, Kambhampati SP, Kudchadkar SR.

J Control Release. 2017 Oct 10;263:192-199. doi: 10.1016/j.jconrel.2017.03.032. Epub 2017 Mar 21.

PMID:
28336376
30.

A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors.

Tolcher AW, Berlin JD, Cosaert J, Kauh J, Chan E, Piha-Paul SA, Amaya A, Tang S, Driscoll K, Kimbung R, Kambhampati SR, Gueorguieva I, Hong DS.

Cancer Chemother Pharmacol. 2017 Apr;79(4):673-680. doi: 10.1007/s00280-017-3245-5. Epub 2017 Mar 9.

31.

Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation.

Soiberman U, Kambhampati SP, Wu T, Mishra MK, Oh Y, Sharma R, Wang J, Al Towerki AE, Yiu S, Stark WJ, Kannan RM.

Biomaterials. 2017 May;125:38-53. doi: 10.1016/j.biomaterials.2017.02.016. Epub 2017 Feb 16.

32.

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors.

LoRusso PM, Gounder M, Jalal SI, André V, Kambhampati SRP, Loizos N, Hall J, Holzer TR, Nasir A, Cosaert J, Kauh J, Chiorean EG.

Invest New Drugs. 2017 Aug;35(4):442-450. doi: 10.1007/s10637-016-0413-0. Epub 2017 Feb 4.

33.

An Open-Label, Dose-Escalation Phase I Study of Anti-TYRP1 Monoclonal Antibody IMC-20D7S for Patients with Relapsed or Refractory Melanoma.

Khalil DN, Postow MA, Ibrahim N, Ludwig DL, Cosaert J, Kambhampati SR, Tang S, Grebennik D, Kauh JS, Lenz HJ, Flaherty KT, Hodi FS, Lawrence DP, Wolchok JD.

Clin Cancer Res. 2016 Nov 1;22(21):5204-5210. Epub 2016 Oct 19.

34.

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia.

Reed GA, Schiller GJ, Kambhampati S, Tallman MS, Douer D, Minden MD, Yee KW, Gupta V, Brandwein J, Jitkova Y, Gronda M, Hurren R, Shamas-Din A, Schuh AC, Schimmer AD.

Cancer Med. 2016 Nov;5(11):3031-3040. doi: 10.1002/cam4.845. Epub 2016 Oct 13.

35.

Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.

Moore M, Gill S, Asmis T, Berry S, Burkes R, Zbuk K, Alcindor T, Jeyakumar A, Chan T, Rao S, Spratlin J, Tang PA, Rothenstein J, Chan E, Bendell J, Kudrik F, Kauh J, Tang S, Gao L, Kambhampati SR, Nasroulah F, Yang L, Ramdas N, Binder P, Strevel E.

Ann Oncol. 2016 Dec;27(12):2216-2224. doi: 10.1093/annonc/mdw412. Epub 2016 Oct 11.

PMID:
27733377
36.

Ileus is a predictor of local infection in patients with acute necrotizing pancreatitis.

Moran RA, Jalaly NY, Kamal A, Rao S, Klapheke R, James TW, Kambhampati S, Makary MA, Hirose K, Kumbhari V, Stein EM, Khashab MA, Lennon AM, Kalloo AN, Zaheer A, Hernaez R, Singh VK.

Pancreatology. 2016 Nov - Dec;16(6):966-972. doi: 10.1016/j.pan.2016.10.002. Epub 2016 Oct 3.

PMID:
27727097
37.

Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer.

Saif MW, Knost JA, Chiorean EG, Kambhampati SR, Yu D, Pytowski B, Qin A, Kauh JS, O'Neil BH.

Cancer Chemother Pharmacol. 2016 Oct;78(4):815-24. doi: 10.1007/s00280-016-3134-3. Epub 2016 Aug 26.

PMID:
27566701
38.

An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer.

Novello S, Scagliotti G, de Castro G Jr, Kiyik M, Kowalyszyn R, Deppermann KM, Arriola E, Bosquee L, Novosiadly RD, Nguyen TS, Forest A, Tang S, Kambhampati SRP, Cosaert J, Reck M.

J Thorac Oncol. 2017 Feb;12(2):383-389. doi: 10.1016/j.jtho.2016.07.013. Epub 2016 Jul 25.

39.

Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.

Zhang F, Nance E, Zhang Z, Jasty V, Kambhampati SP, Mishra MK, Burd I, Romero R, Kannan S, Kannan RM.

J Control Release. 2016 Sep 10;237:61-70. doi: 10.1016/j.jconrel.2016.06.046. Epub 2016 Jul 1.

40.

Myelodysplastic Syndrome with concomitant t(5;21)(q15;q22) and del(5)(q13q33): case report and review of literature.

Kasi Loknath Kumar A, Weckbaugh B, Sirridge C, Woodroof J, Persons D, Kambhampati S.

Stem Cell Investig. 2016 Feb 23;3:3. doi: 10.3978/j.issn.2306-9759.2016.02.01. eCollection 2016.

41.

Sebaceous cell carcinoma developing in epidermodysplasia verruciformis.

Kambhampati SB, Vinay K, De D, Handa S, Gaspar BL, Saikia UN.

Indian J Dermatol Venereol Leprol. 2016 Jul-Aug;82(4):433-5. doi: 10.4103/0378-6323.175909. No abstract available.

42.

Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.

Nance E, Zhang F, Mishra MK, Zhang Z, Kambhampati SP, Kannan RM, Kannan S.

Biomaterials. 2016 Sep;101:96-107. doi: 10.1016/j.biomaterials.2016.05.044. Epub 2016 May 26.

43.

Shared Decision-Making and Patient Empowerment in Preventive Cardiology.

Kambhampati S, Ashvetiya T, Stone NJ, Blumenthal RS, Martin SS.

Curr Cardiol Rep. 2016 May;18(5):49. doi: 10.1007/s11886-016-0729-6. Review.

PMID:
27098670
44.

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial.

Garcia-Manero G, Fenaux P, Al-Kali A, Baer MR, Sekeres MA, Roboz GJ, Gaidano G, Scott BL, Greenberg P, Platzbecker U, Steensma DP, Kambhampati S, Kreuzer KA, Godley LA, Atallah E, Collins R Jr, Kantarjian H, Jabbour E, Wilhelm FE, Azarnia N, Silverman LR; ONTIME study investigators.

Lancet Oncol. 2016 Apr;17(4):496-508. doi: 10.1016/S1470-2045(16)00009-7. Epub 2016 Mar 9.

PMID:
26968357
45.

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.

Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A.

Lancet Haematol. 2015 Oct;2(10):e417-26. doi: 10.1016/S2352-3026(15)00149-0. Epub 2015 Oct 1.

PMID:
26686043
46.

Unified framework for triaxial accelerometer-based fall event detection and classification using cumulants and hierarchical decision tree classifier.

Kambhampati SS, Singh V, Manikandan MS, Ramkumar B.

Healthc Technol Lett. 2015 Aug 3;2(4):101-7. doi: 10.1049/htl.2015.0018. eCollection 2015 Aug.

47.

Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.

Li W, Morrone K, Kambhampati S, Will B, Steidl U, Verma A.

Leukemia. 2016 Mar;30(3):536-44. doi: 10.1038/leu.2015.297. Epub 2015 Oct 26. Review.

PMID:
26500138
48.

Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes.

Garcia-Manero G, Gore SD, Kambhampati S, Scott B, Tefferi A, Cogle CR, Edenfield WJ, Hetzer J, Kumar K, Laille E, Shi T, MacBeth KJ, Skikne B.

Leukemia. 2016 Apr;30(4):889-96. doi: 10.1038/leu.2015.265. Epub 2015 Oct 7.

49.

Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia.

Ganguly S, Home T, Yacoub A, Kambhampati S, Shi H, Dandawate P, Padhye S, Saluja AK, McGuirk J, Rao R.

Oncotarget. 2015 Oct 13;6(31):31767-79. doi: 10.18632/oncotarget.5167.

50.

Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina.

Kambhampati SP, Clunies-Ross AJ, Bhutto I, Mishra MK, Edwards M, McLeod DS, Kannan RM, Lutty G.

Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4413-24. doi: 10.1167/iovs.14-16250.

Supplemental Content

Loading ...
Support Center